UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome

Current diabetes reports, 2020-07, Vol.20 (7), p.26-26, Article 26

2020

Volltextzugriff (PDF)

Eating Slowly Increases the Postprandial Response of the Anorexigenic Gut Hormones, Peptide YY and Glucagon-Like Peptide-1

The journal of clinical endocrinology and metabolism, 2010-01, Vol.95 (1), p.333-337

2010

Volltextzugriff (PDF)

The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action

Trends in cardiovascular medicine, 2024-03

2024

Volltextzugriff (PDF)

Management of Diabetic Foot Ulcers

Diabetes therapy, 2012-12, Vol.3 (1), p.1-4, Article 4

2012

Volltextzugriff (PDF)

Increased glycemic variability in pregnant women with Roux-en-Y gastric bypass compared with sleeve gastrectomy

BMJ open diabetes research & care, 2024-01, Vol.12 (1), p.e003642

2024

Volltextzugriff (PDF)

Meal-induced thermogenesis and macronutrient oxidation in lean and obese women after consumption of carbohydrate-rich and fat-rich meals

Nutrition (Burbank, Los Angeles County, Calif.), 2011-03, Vol.27 (3), p.310-315

2011

Volltextzugriff (PDF)

Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study

BMJ open diabetes research & care, 2020-03, Vol.8 (1), p.e001076

2020

Volltextzugriff (PDF)

Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy

iScience, 2023-11, Vol.26 (11), p.108190-108190, Article 108190

2023

Volltextzugriff (PDF)

Cracking the combination: Gut hormones for the treatment of obesity and diabetes

Journal of neuroendocrinology, 2019-05, Vol.31 (5), p.e12664-n/a

2019

Volltextzugriff (PDF)

Standard and emerging treatment options for diabetic neuropathy

Current pharmaceutical design, 2014-01, Vol.20 (22), p.3689-3704

2014

Volltextzugriff (PDF)

Nuts: Anti-atherogenic food?

European journal of internal medicine, 2011-04, Vol.22 (2), p.141-146

2011

Volltextzugriff (PDF)

Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation

Diabetes care, 2010-07, Vol.33 (7), p.1523-1528

2010

Volltextzugriff (PDF)

Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis

Obesity surgery, 2018-12, Vol.28 (12), p.3997-4005

2018

Volltextzugriff (PDF)

The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction

The journal of clinical endocrinology and metabolism, 2022-02, Vol.107 (2), p.e767-e782

2022

Volltextzugriff (PDF)

Weight Loss by Low-Calorie Diet Versus Gastric Bypass Surgery in People With Diabetes Results in Divergent Brain Activation Patterns: A Functional MRI Study

Diabetes care, 2021-08, Vol.44 (8), p.1842-1851

2021

Volltextzugriff (PDF)

Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study

Diabetes care, 2021-02, Vol.44 (2), p.614-617

2021

Volltextzugriff (PDF)

Improvement in Cardiovascular Indices After Roux-en-Y Gastric Bypass or Sleeve Gastrectomy for Morbid Obesity

Obesity surgery, 2013, Vol.23 (1), p.31-38

2013

Volltextzugriff (PDF)

Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single‐blind placebo‐controlled study

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1731-1739

2023

Volltextzugriff (PDF)

Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial

Diabetes, obesity & metabolism, 2024-04, Vol.26 (4), p.1479-1491

2024

Volltextzugriff (PDF)

The postprandial secretion of peptide YY1‐36 and 3‐36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy

Clinical endocrinology (Oxford), 2023-09, Vol.99 (3), p.272-284

2023

Volltextzugriff (PDF)

The postprandial secretion of peptide YY 1-36 and 3-36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy

Clinical endocrinology (Oxford), 2023-09, Vol.99 (3), p.272-284

2023

Volltextzugriff (PDF)

Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study

Diabetes care, 2010-07, Vol.33 (7), p.1523-1528

2010

Volltextzugriff (PDF)

Commentary on “The road to reliable peptide assays is paved with good guidelines”

Clinical endocrinology (Oxford), 2023-06, Vol.98 (6), p.763-765

2023

Volltextzugriff (PDF)

390-P: Changes in Glycaemic Variability after RYGB: A One-Year Prospective Study with Comparison to Patients with Post-bariatric Hypoglycaemia

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome

Eating Slowly Increases the Postprandial Response of the Anorexigenic Gut Hormones, Peptide YY and Glucagon-Like Peptide-1

The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action

Management of Diabetic Foot Ulcers

Increased glycemic variability in pregnant women with Roux-en-Y gastric bypass compared with sleeve gastrectomy

Meal-induced thermogenesis and macronutrient oxidation in lean and obese women after consumption of carbohydrate-rich and fat-rich meals

Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study

Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy

Cracking the combination: Gut hormones for the treatment of obesity and diabetes

Standard and emerging treatment options for diabetic neuropathy

Nuts: Anti-atherogenic food?

Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation

Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study

Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis

The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction

Weight Loss by Low-Calorie Diet Versus Gastric Bypass Surgery in People With Diabetes Results in Divergent Brain Activation Patterns: A Functional MRI Study

Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study

Improvement in Cardiovascular Indices After Roux-en-Y Gastric Bypass or Sleeve Gastrectomy for Morbid Obesity

Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single‐blind placebo‐controlled study

Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial

The postprandial secretion of peptide YY1‐36 and 3‐36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy

The postprandial secretion of peptide YY 1-36 and 3-36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy

Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study

Commentary on “The road to reliable peptide assays is paved with good guidelines”

390-P: Changes in Glycaemic Variability after RYGB: A One-Year Prospective Study with Comparison to Patients with Post-bariatric Hypoglycaemia

Suchergebnisse filtern